Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
New Study Appears To Confirm Link Between Roundup and Cancer Evidence about the side effects of glyphosate in Roundup on rats is seen as supporting evidence for IARC decision to classify the weedkiller as a human carcinogen. July 7, 2025 Irvin Jackson Add Your Comments The findings of a new study appear to add to the growing evidence that exposure to glyphosate, the active ingredient in Roundup weed killer products, can increase a person’s risk of cancer. In a report published in the medical journal Environmental Health on June 10, Italian researchers detail experiments on rats, which show a dose-dependent increase in the development of tumors when exposed to glyphosate. Dose-dependent relationships are often considered strong evidence of a causal relationship. The study comes as Bayer and its Monsanto subsidiary continue to face tens of thousands of Roundup lawsuits, each claiming that the manufacturers failed to provide adequate warnings about the link between Roundup and cancer, specifically the risk that users may develop non-Hodgkins lymphoma. More than 90,000 consumers have filed claims after they were diagnosed with non-Hodgkins lymphoma from Roundup, and Bayer has already agreed to pay more than $10 billion in Roundup settlements. However, the litigation appears to have no end in sight, with a steady stream of trials scheduled involving individuals who declined the settlement offers, as well as new claims that continue to be filed as former users develop non-Hodgkin’s lymphoma. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, researchers looked at the side effects of glyphosate exposure from various different herbicides, including Roundup, Bioflow and RangerPro. Led by Philip J. Landrigan, Fiorella Belpoggi and Daniele Mandrioli of the Cesare Maltoni Cancer Research Center in Italy, the team tested the rats at corresponding levels of exposure that a human would face under European Union acceptable daily glyphosate intake limits of 0.5 mg per kilogram of body weight per day. “In all 3 treatment groups, statistically significant dose-related increased trends or increased incidences of benign and malignant tumors at multiple anatomic sites were observed compared to historical and concurrent controls. These tumors arose in haemolymphoreticular tissues (leukemia), skin, liver, thyroid, nervous system, ovary, mammary gland, adrenal glands, kidney, urinary bladder, bone, endocrine pancreas, uterus and spleen (hemangiosarcoma). Increased incidences occurred in both sexes.” –Carcinogenic effects of long-term exposure from prenatal life to glyphosate and glyphosate-based herbicides in Sprague–Dawley rats According to the data, most of the tumors were rare in these types of rats, with a background incidence rate of less than 1%, including leukemia. Early life exposure to glyphosate led to increased risk of multiple tumors and early death, the researchers warned. Roundup Cancer Warnings The findings come more than a decade after the World Health Organization’s International Agency for Research on Cancer (IARC) issued a Roundup cancer warning in March 2015, classifying glyphosate as a “probable carcinogen.” The researchers in this latest study specifically pointed to their findings as new evidence that the IARC was correct in its assessment, which linked the weed killer to an increased risk of non-Hodgkins lymphoma. Bayer has continued to defend the safety of Roundup, even as it settled tens of thousands of claims. However, following numerous failures in federal courts nationwide, including the Supreme Court, recent reports indicate the company has turned its efforts to the states, trying to convince them to provide lawsuit protection. Its efforts have already resulted in liability protections in Georgia and North Carolina, with similar measures being considered by several other states. The company has also filed a Writ of Certiorari with the U.S. Supreme Court that argues the failure to warn claims should be barred by federal preemption, since the herbicide was approved by federal regulators. It is the company’s third attempt to get the U.S. Supreme Court to weigh in on the litigation, with the petition coming after the Missouri Supreme Court rejected a similar Roundup appeal in February, when it upheld a $1.25 million Roundup damage award from October 2023. To cut off the potential for future claims, Bayer also announced that it would reformulate Roundup in 2021, with plans to remove the active ingredient glyphosate from consumer versions of the weed killer. However, without additional settlements, the company is likely to continue facing new lawsuits for years, as former users develop non-Hodgkin’s lymphoma following use of the old Roundup formulations. Tags: Bayer, Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer Image Credit: Shutterstock – Billy F Blume Jr More Roundup Stories U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 Bayer’s Roundup Settlement Plan May Result in Monsanto Bankruptcy Filing: Report May 19, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025) Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)